|Articles|October 30, 2019
HCP Monitoring in Downstream Process Samples
Author(s)PharmaFluidics
μPAC™ technology has been used for analysing HCP impurities originating from recombinant expression systems used in the production of mAb based biotherapeutics.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Mass Spectrometry–Driven Strategies for Membrane Protein–Targeted Drug Discovery
2
Thermo Fisher and NVIDIA Partner to Expand AI Driven Laboratory Automation
3
Isotope Dilution HPLC–MS/MS Analysis of Serum Cotinine Reveals Environmental Tobacco Smoke–Associated PID Risk
4
Ep. 43: An Introduction to Optical Photothermal Infrared (O-PTIR) Spectroscopy
5